Compare GSK Pharma with Elder Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs ELDER PHARMA - Comparison Results

GSK PHARMA     Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA ELDER PHARMA GSK PHARMA/
ELDER PHARMA
 
P/E (TTM) x 50.2 -0.2 - View Chart
P/BV x 11.3 0.1 11,232.3% View Chart
Dividend Yield % 1.4 0.0 -  

Financials

 GSK PHARMA   ELDER PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-19
ELDER PHARMA
Jun-14
GSK PHARMA/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs3,595380 946.1%   
Low Rs1,253188 666.5%   
Sales per share (Unadj.) Rs184.7491.2 37.6%  
Earnings per share (Unadj.) Rs26.3-3.2 -826.4%  
Cash flow per share (Unadj.) Rs29.214.4 202.4%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs126.3376.5 33.5%  
Shares outstanding (eoy) m169.4020.54 824.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x13.10.6 2,270.4%   
Avg P/E ratio x92.2-89.3 -103.3%  
P/CF ratio (eoy) x83.119.7 421.7%  
Price / Book Value ratio x19.20.8 2,544.0%  
Dividend payout %76.10-   
Avg Mkt Cap Rs m410,6265,833 7,039.3%   
No. of employees `0005.0NA-   
Total wages/salary Rs m5,3722,179 246.5%   
Avg. sales/employee Rs Th6,306.7NM-  
Avg. wages/employee Rs Th1,083.1NM-  
Avg. net profit/employee Rs Th898.0NM-  
INCOME DATA
Net Sales Rs m31,28110,089 310.1%  
Other income Rs m1,023257 398.7%   
Total revenues Rs m32,30410,346 312.2%   
Gross profit Rs m6,009-792 -758.8%  
Depreciation Rs m486361 134.5%   
Interest Rs m62,756 0.2%   
Profit before tax Rs m6,540-3,653 -179.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2873,713 7.7%   
Tax Rs m2,373125 1,896.1%   
Profit after tax Rs m4,454-65 -6,815.6%  
Gross profit margin %19.2-7.8 -244.7%  
Effective tax rate %36.3-3.4 -1,059.1%   
Net profit margin %14.2-0.6 -2,198.2%  
BALANCE SHEET DATA
Current assets Rs m20,0619,240 217.1%   
Current liabilities Rs m14,5439,998 145.5%   
Net working cap to sales %17.6-7.5 -234.9%  
Current ratio x1.40.9 149.3%  
Inventory Days Days5746 122.6%  
Debtors Days Days1460 23.5%  
Net fixed assets Rs m14,34310,124 141.7%   
Share capital Rs m1,694206 823.5%   
"Free" reserves Rs m19,7045,582 353.0%   
Net worth Rs m21,3987,734 276.7%   
Long term debt Rs m24,889 0.0%   
Total assets Rs m39,11322,882 170.9%  
Interest coverage x1,091.0-0.3 -335,391.8%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.4 181.4%   
Return on assets %11.411.8 97.0%  
Return on equity %20.8-0.8 -2,463.2%  
Return on capital %31.922.3 143.1%  
Exports to sales %03.0 0.0%   
Imports to sales %00.4 0.0%   
Exports (fob) Rs mNA307 0.0%   
Imports (cif) Rs mNA43 0.0%   
Fx inflow Rs m534307 174.2%   
Fx outflow Rs m7,091125 5,659.2%   
Net fx Rs m-6,557181 -3,616.7%   
CASH FLOW
From Operations Rs m3,99411,754 34.0%  
From Investments Rs m-1,433-561 255.7%  
From Financial Activity Rs m-3,584-6,762 53.0%  
Net Cashflow Rs m-1,0234,432 -23.1%  

Share Holding

Indian Promoters % 0.0 39.6 -  
Foreign collaborators % 50.7 0.0 -  
Indian inst/Mut Fund % 10.2 7.5 136.0%  
FIIs % 23.8 16.8 141.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 15.4 36.1 42.7%  
Shareholders   102,036 16,479 619.2%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   AJANTA PHARMA  FDC  SUN PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 244 Points Lower, Nifty Ends Below 14,300; UltraTech Cement & HCL Tech Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Apr 20, 2021 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA 8-QTR ANALYSIS

COMPARE GSK PHARMA WITH

MARKET STATS